×
About 1,365 results

ALLMedicine™ Cerebral Venous Thrombosis Center

Research & Reviews  476 results

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: ...
https://doi.org/10.1161/STROKEAHA.122.039579
Stroke Yaghi S, Saldanha IJ et. al.

Aug 9th, 2022 - High level evidence for direct oral anticoagulants (DOACs) in patients with cerebral venous thrombosis is lacking. We performed a systematic review and meta-analysis to assess the efficacy and safety of DOACs versus vitamin K antagonists in patien...

Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283127
Clinical Imaging; Franceschi AM, Petrover DR et. al.

Aug 5th, 2022 - Cerebral Venous Thrombosis (CVT), prior to the COVID pandemic, was rare representing 0.5 of all strokes, with the diagnosis made by MRI or CT venography.1-,3 COVID-19 patients compared to general populations have a 30-60 times greater risk of CVT ...

Role of MRI and CT in the Evaluation of Headache in Pregnancy and the Postpartum Period.
https://doi.org/10.1016/j.ncl.2022.02.010
Neurologic Clinics; Zamora C, Castillo M

Jul 26th, 2022 - Approximately 35% of acute headaches in pregnant women are secondary to an underlying condition. Headaches are also common in the postpartum period where they occur in 30% to 40% of patients. The majority of secondary headaches are due to hyperten...

Imaging of Headache Attributed to Vascular Disorders.
https://doi.org/10.1016/j.ncl.2022.02.004
Neurologic Clinics; Wang LL, Mahammedi A et. al.

Jul 26th, 2022 - Imaging is essential in the diagnosis of vascular causes of headaches. With advances in technology, there are increasing options of imaging modalities to choose from, each with its own advantages and disadvantages. This article will focus on imagi...

Cerebral Venous Thrombosis With Topical Estrogen-Progesterone Use in a Young Heterosexu...
https://doi.org/10.1097/NRL.0000000000000455
The Neurologist; Aldraihem MO, Al-Senani F et. al.

Jul 21st, 2022 - Our report sheds light on the risk of topical hormonal use in relation to cerebral venous sinus thrombosis. We diagnosed our patient with cerebral venous thrombosis (CVT) using computed tomography venogram, then detailed history and examination we...

see more →

Guidelines  2 results

European Stroke Organization guideline for the diagnosis and treatment of cerebral veno...
https://doi.org/10.1111/ene.13381
European Journal of Neurology; Ferro JM, Bousser MG et. al.

Aug 24th, 2017 - Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines usin...

New guidelines for the management of cerebral venous thrombosis.
https://doi.org/10.1227/01.neu.0000400016.31648.3f
Neurosurgery Aoun SG, Rahme RJ et. al.

Jul 28th, 2011 - New guidelines for the management of cerebral venous thrombosis.|2011|Aoun SG,Rahme RJ,Batjer HH,Bendok BR,|therapeutic use,diagnosis,therapy,diagnosis,therapy,

see more →

Drugs  1 results see all →

Clinicaltrials.gov  22 results

National Real-world Study of Cerebral Venous Thrombosis in China
https://clinicaltrials.gov/ct2/show/NCT05448248

Jul 7th, 2022 - The epidemiology, risk factors, diagnosis and treatment of Cerebral Venous Thrombosis (CVT) in China are still unclear. A retrospective hospital-based study will be conducted at fifty different hospitals across 31 provinces in China. This study wi...

The Norwegian Cerebral Venous Thrombosis Study
https://clinicaltrials.gov/ct2/show/NCT05021198

Jun 8th, 2022 - A retrospective hospital-based chart review will be conducted at eight different hospitals covering all four health regions and more than 3 million inhabitants in Norway. These eight hospitals are Akershus University Hospital, Haukeland University...

Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
https://clinicaltrials.gov/ct2/show/NCT03329365

May 11th, 2022 - Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal hematological disorder leading to red blood cells hemolysis and thrombosis. PNH has been reported to be the cause of cerebral venous thrombosis and embolic ischemic strokes and is...

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
https://clinicaltrials.gov/ct2/show/NCT04660747

Feb 28th, 2022 - Rationale: Patients with cerebral venous thrombosis (CVT) are currently treated with anticoagulants during 3-12 months after diagnosis, to prevent worsening of the CVT and recurrent thrombosis, and to promote venous recanalization. Until recently,...

Cytokine Registry Database of Stroke Patients
https://clinicaltrials.gov/ct2/show/NCT03297827

Feb 8th, 2022 - Stroke is the fifth cause of all-cause mortality in US http://www.cdc.gov/stroke/facts.htm . Early identification and treatment not only prevent mortality but also morbidity. Recent advancement in the imaging and diagnostic technique and novel the...

see more →

News  45 results

Study Confirms Increased CVT With AstraZeneca COVID Vaccine
https://www.medscape.com/viewarticle/976487

Jul 1st, 2022 - A new Scandinavian study has confirmed previous data showing increased rates of cerebral venous thrombosis and thrombocytopenia after the AstraZeneca COVID-19 vaccine. The study also showed higher rates of several thromboembolic and thrombocytopen...

Neurologic Complications Rare After COVID-19 Vaccines
https://www.medpagetoday.com/neurology/generalneurology/97590

Mar 9th, 2022 - Neurologic adverse events after COVID-19 vaccination were rare, an analysis of Vaccine Adverse Event Reporting System (VAERS) data showed. Of nearly 307 million COVID vaccine doses administered in the U.S. in the first half of 2021, 314,610 (0.1%)...

Headache and Covid-19: What clinicians should know
https://www.mdedge.com/migraine-icymi/article/252097/headache-migraine/headache-and-covid-19-what-clinicians-should-know
Edoardo Caronna, MD and Patricia Pozo-Rosich et. al.

Feb 23rd, 2022 - Edoardo Caronna, MD and Patricia Pozo-Rosich, MD, PhD, Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; and Headache and Neurological Pain Research Group, Vall.

DOACs Comparable to Warfarin in CVT
https://www.medscape.com/viewarticle/968526

Feb 15th, 2022 - Use of direct oral anticoagulant drugs (DOACs) appears to be just as effective as warfarin in preventing future thrombotic events in patients with cerebral venous thrombosis (CVT) stroke, and are less likely to result in major bleeding, a retrospe...

Reaching Conclusions From Limited Data Holds Pitfalls
https://www.onclive.com/view/reaching-conclusions-from-limited-data-holds-pitfalls

Oct 6th, 2021 - There are most interesting and complex days in the continuing evolution of the COVID-19 pandemic. On one hand, in the United States and a number of other countries, mass vaccination strategies have finally begun to have a major impact on the incid...

see more →